
Taofiq A Solola
Examiner (ID: 14120, Phone: (571)272-0709 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1626, 1625, 1622, 1613 |
| Total Applications | 3196 |
| Issued Applications | 2336 |
| Pending Applications | 272 |
| Abandoned Applications | 640 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15960405
[patent_doc_number] => 20200163954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-28
[patent_title] => Dosing of Cabozantinib Formulations
[patent_app_type] => utility
[patent_app_number] => 16/776139
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10832
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16776139
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/776139 | Dosing of Cabozantinib Formulations | Jan 28, 2020 | Abandoned |
Array
(
[id] => 16268982
[patent_doc_number] => 20200270469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => ACTIVE-ENERGY-RAY-POLYMERIZABLE INITIATOR, ACTIVE-ENERGY-RAY-POLYMERIZABLE COMPOSITION, ACTIVE-ENERGY-RAY-POLYMERIZABLE INK, INK STORAGE CONTAINER, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS
[patent_app_type] => utility
[patent_app_number] => 16/774636
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774636
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774636 | Active-energy-ray-polymerizable initiator, active-energy-ray-polymerizable composition, active-energy-ray-polymerizable ink, ink storage container, image forming method, and image forming apparatus | Jan 27, 2020 | Issued |
Array
(
[id] => 17742567
[patent_doc_number] => 11390624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-19
[patent_title] => Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/774086
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29941
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 3566
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774086 | Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors | Jan 27, 2020 | Issued |
Array
(
[id] => 16853428
[patent_doc_number] => 20210154173
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => PHARMACEUTICAL COMPOSITION INCLUDING CLAVULANIC ACID AND VALPROIC ACID, METHOD FOR TREATMENT OF EPILEPSY SEIZURE, AND METHOD FOR TREATMENT OF EPILEPSY-ASSOCIATED MOTOR SYMPTOM AND COGNITIVE IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 16/747917
[patent_app_country] => US
[patent_app_date] => 2020-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747917
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747917 | PHARMACEUTICAL COMPOSITION INCLUDING CLAVULANIC ACID AND VALPROIC ACID, METHOD FOR TREATMENT OF EPILEPSY SEIZURE, AND METHOD FOR TREATMENT OF EPILEPSY-ASSOCIATED MOTOR SYMPTOM AND COGNITIVE IMPAIRMENT | Jan 20, 2020 | Abandoned |
Array
(
[id] => 15898267
[patent_doc_number] => 20200148652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => Aminothiazole Derivatives Useful As Antiviral Agents
[patent_app_type] => utility
[patent_app_number] => 16/747061
[patent_app_country] => US
[patent_app_date] => 2020-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 1058
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747061
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/747061 | Aminothiazole Derivatives Useful As Antiviral Agents | Jan 19, 2020 | Abandoned |
Array
(
[id] => 19961563
[patent_doc_number] => 12331047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-17
[patent_title] => Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alpha]pyridine-3-carbonyl)-2-hydroxybenzonitrile
[patent_app_type] => utility
[patent_app_number] => 17/310123
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1236
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310123 | Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alpha]pyridine-3-carbonyl)-2-hydroxybenzonitrile | Jan 16, 2020 | Issued |
Array
(
[id] => 16359296
[patent_doc_number] => 20200316047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/744551
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744551
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744551 | Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound | Jan 15, 2020 | Issued |
Array
(
[id] => 15927991
[patent_doc_number] => 20200155629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => Purified Synthetic Marijuana And Methods Of Treatment By Administering Same
[patent_app_type] => utility
[patent_app_number] => 16/739219
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739219 | Purified synthetic marijuana and methods of treatment by administering same | Jan 9, 2020 | Issued |
Array
(
[id] => 15828501
[patent_doc_number] => 20200129532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-30
[patent_title] => USE OF BROMODOMAIN-CONTAINING PROTEIN 9 ANTAGONISTS IN COMBINATION WITH VITAMIN D RECEPTOR AGONISTS IN DIABETES TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/737312
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737312
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737312 | Use of bromodomain-containing protein 9 antagonists in combination with vitamin D receptor agonists in diabetes treatment | Jan 7, 2020 | Issued |
Array
(
[id] => 17467612
[patent_doc_number] => 11274080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-15
[patent_title] => Diamino pyridine derivatives
[patent_app_type] => utility
[patent_app_number] => 16/737366
[patent_app_country] => US
[patent_app_date] => 2020-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5773
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16737366
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/737366 | Diamino pyridine derivatives | Jan 7, 2020 | Issued |
Array
(
[id] => 17554893
[patent_doc_number] => 11311550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Treatment for cellulitis and pre-operative treatment
[patent_app_type] => utility
[patent_app_number] => 16/729670
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 12
[patent_no_of_words] => 2803
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16729670
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/729670 | Treatment for cellulitis and pre-operative treatment | Dec 29, 2019 | Issued |
Array
(
[id] => 17685810
[patent_doc_number] => 20220193102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-23
[patent_title] => COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
[patent_app_type] => utility
[patent_app_number] => 17/600168
[patent_app_country] => US
[patent_app_date] => 2019-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27997
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17600168
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/600168 | COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD) | Dec 26, 2019 | Abandoned |
Array
(
[id] => 16206500
[patent_doc_number] => 20200239490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => PYRIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/722592
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9077
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/722592 | Pyridine derivatives | Dec 19, 2019 | Issued |
Array
(
[id] => 18525454
[patent_doc_number] => 11712432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Method of treating cancer with an elevated glycogen content
[patent_app_type] => utility
[patent_app_number] => 16/724126
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 118
[patent_no_of_words] => 17933
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16724126
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/724126 | Method of treating cancer with an elevated glycogen content | Dec 19, 2019 | Issued |
Array
(
[id] => 17656976
[patent_doc_number] => 20220177441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => METHOD OF PRODUCING REFINED OILS AND/OR FATS, AND METHOD FOR PRODUCING TOCOPHEROLS
[patent_app_type] => utility
[patent_app_number] => 17/593023
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7929
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17593023
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/593023 | Method of producing refined oils and/or fats, and method for producing tocopherols | Dec 19, 2019 | Issued |
Array
(
[id] => 16999395
[patent_doc_number] => 11078185
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/720659
[patent_app_country] => US
[patent_app_date] => 2019-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12226
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720659
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/720659 | None | Dec 18, 2019 | Issued |
Array
(
[id] => 16970416
[patent_doc_number] => 11066376
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant
[patent_app_type] => utility
[patent_app_number] => 16/718334
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17406
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16718334
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/718334 | Production of purified dialkyl-furan-2,5-dicarboxylate (DAFD) in a retrofitted DMT plant | Dec 17, 2019 | Issued |
Array
(
[id] => 16907604
[patent_doc_number] => 11039617
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
[patent_app_type] => utility
[patent_app_number] => 16/707516
[patent_app_country] => US
[patent_app_date] => 2019-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28683
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 221
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707516
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/707516 | Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness | Dec 8, 2019 | Issued |
Array
(
[id] => 17368330
[patent_doc_number] => 20220023382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => VDAC INHIBITORS FOR TREATING INFLAMMATORY BOWEL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/297046
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15154
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297046
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297046 | VDAC INHIBITORS FOR TREATING INFLAMMATORY BOWEL DISEASES | Nov 25, 2019 | Pending |
Array
(
[id] => 15740489
[patent_doc_number] => 20200109132
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/696817
[patent_app_country] => US
[patent_app_date] => 2019-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 417
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16696817
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/696817 | SUBSTITUTED PYRAZOLE COMPOUNDS AS SERINE PROTEASE INHIBITORS | Nov 25, 2019 | Abandoned |